Michael Mullette
Directeur des opérations chez Lykos Therapeutics PBC
Postes actifs de Michael Mullette
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Lykos Therapeutics PBC
 Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Directeur des opérations | 01/03/2022 | - |
Historique de carrière de Michael Mullette
Anciens postes connus de Michael Mullette
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MODERNA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Health Technology |
- Bourse
- Insiders
- Michael Mullette
- Expérience
